Composite
UPll+AckRS

Part:BBa_K1722007:Design

Designed by: Hui Ai   Group: iGEM15_SZU_China   (2015-09-02)

hUPll+AckRS Composite


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal XhoI site found at 1622
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 811
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

The AckRS gene that is achieved from Shenzhen Second People's Hospital has two EcoR1 restriction enzyme cutting sites in its sequence. We mutated them and designed primers to amplified both hUPll and AckRS from psi-Check2 vector. Then 3A Assembly was used to construct these two gene in pSB1C3.

Source

We achieved both hUPll promoter and AckRS from Shenzhen Second People's Hospital.

References

[1]Wu XR, Lin JH, Walz T, et al. Mammalian uroplakins, a group of highly conserved urothelial differentiation related membrane proteins. J Biol Chem. 1994;269:13716–13724.

[2]Yuasa T, Yoshiki T, Isono T, et al. Expression of transitional cell specific genes uroplakin Ia and II in bladder cancer detection of circulating cancer cells in the peripheral blood of metastatic patients. Int J Urol. 1999;6:286–292.

[3]Moll R, Wu XR, Lin JH, Sun TT. Uroplakins specific membrane proteins of urothelial umbrella cells as histological markers of metastatic transitional cell carcinomas. Am J Pathol. 1995;147:1383–1397.

[4]Zhu H J, Zhang ZQ, Zeng XF, et al. Cloning and analysis of human uroplakin II promoter and its ap plication for gene therapy in bladder cancer[J] Cancer Gene Ther, 2004, 11: 263-272

[5] Hausmann C D, Ibba M. Aminoacyl- tRNA synthetase complexes: molecular multitasking revealed. FEMS Microbiol Rev, 2008, 32(4): 705-721

[6] Han JM, Kim J Y, Kim S. Molecular network and functional implications of macromolecular tRNA synthetase complex. Biochem Biophys Res Commun, 2003, 303(4): 985-993

[7] Veronika F, Milan V, Sabine S. Structural basis for the site-specific Incorporation of Lysine Derivatives into Proteins. Plos One, 2014, 9(4): 1-7